7203 related articles for article (PubMed ID: 3104215)
1. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes.
Holzmann B; Bröcker EB; Lehmann JM; Ruiter DJ; Sorg C; Riethmüller G; Johnson JP
Int J Cancer; 1987 Apr; 39(4):466-71. PubMed ID: 3104215
[TBL] [Abstract][Full Text] [Related]
2. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic dynamics of tumor progression in human malignant melanoma.
Bröcker EB; Suter L; Brüggen J; Ruiter DJ; Macher E; Sorg C
Int J Cancer; 1985 Jul; 36(1):29-35. PubMed ID: 3860479
[TBL] [Abstract][Full Text] [Related]
4. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
7. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
Herlyn M; Guerry D; Koprowski H
J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706
[TBL] [Abstract][Full Text] [Related]
8. Growth and phenotypic characteristics of human nevus cells in culture.
Mancianti ML; Herlyn M; Weil D; Jambrosic J; Rodeck U; Becker D; Diamond L; Clark WH; Koprowski H
J Invest Dermatol; 1988 Feb; 90(2):134-41. PubMed ID: 2828480
[TBL] [Abstract][Full Text] [Related]
9. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
10. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.
Holzmann B; Johnson JP; Kaudewitz P; Riethmüller G
J Exp Med; 1985 Feb; 161(2):366-77. PubMed ID: 3973533
[TBL] [Abstract][Full Text] [Related]
11. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
12. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gamma.
Anichini A; Mortarini R; Fossati G; Parmiani G
Int J Cancer; 1986 Oct; 38(4):505-11. PubMed ID: 3093392
[TBL] [Abstract][Full Text] [Related]
14. Superficial spreading melanoma with a nodular area: antigenic phenotype of the radial and vertical growth areas.
Brogelli L; Moretti S; Giannotti B
Tumori; 1989 Feb; 75(1):8-11. PubMed ID: 2711482
[TBL] [Abstract][Full Text] [Related]
15. [Step-wise expression of melanoma-associated antigens in tumor progression].
Lehmann JM; Holzmann B; Rothbächer U; Riethmüller G; Johnson JP
Onkologie; 1989 Dec; 12(6):273-6. PubMed ID: 2696911
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
17. Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma.
Ernstoff MS; Duray P; Stenn K; Kirkwood JM
J Invest Dermatol; 1985 May; 84(5):430-2. PubMed ID: 3889169
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon.
Giacomini P; Fraioli R; Nistico P; Tecce R; Nicotra MR; Di Filippo F; Fisher PB; Natali PG
Int J Cancer; 1990 Sep; 46(3):539-45. PubMed ID: 2118485
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression.
Bröcker EB; Zwadlo G; Holzmann B; Macher E; Sorg C
Int J Cancer; 1988 Apr; 41(4):562-7. PubMed ID: 3128489
[TBL] [Abstract][Full Text] [Related]
20. Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.
von Stamm U; Bröcker EB; von Depka Prondzinski M; Ruiter DJ; Rümke P; Broding C; Carrel S; Lejeune FJ
Melanoma Res; 1993 Jun; 3(3):173-80. PubMed ID: 8104570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
